Platform
Company
Complete Blood Count
Review status
Currently under review
Pending specialist review and validation.
Hemoglobin A2 is a small fraction of the hemoglobin found in your red blood cells. It is one of several types of hemoglobin, made from two alpha and two delta protein chains. Laboratories measure it as a percentage of your total hemoglobin using techniques such as high-performance liquid chromatography or capillary electrophoresis.
This test is usually part of a hemoglobin evaluation when your clinician is looking for inherited hemoglobin conditions or trying to understand the cause of anemia or small red blood cells. It does not require any special preparation and is performed on a standard blood sample.
Measuring Hemoglobin A2 helps identify carrier states of certain inherited blood conditions, especially beta thalassemia trait. It can also provide clues about other hemoglobin variants and helps distinguish between different causes of anemia, such as iron deficiency versus a genetic trait. Understanding your HbA2 level can guide appropriate follow-up testing and counseling.
Clinicians often order this test when your complete blood count shows small red blood cells, when there is a family history or ethnic background associated with hemoglobin disorders, or during prenatal and preconception carrier screening. Results can inform decisions about partner testing, genetic counseling, and management of anemia.
Your HbA2 result is interpreted together with your complete blood count, iron studies, and other hemoglobin fraction results. A value higher than what is typical may suggest a carrier state for beta thalassemia or certain hemoglobin variants, while a lower value can be seen with specific genetic patterns or conditions that affect red blood cell production. Iron status, vitamin levels, and recent transfusions can change the result, so your clinician will consider these factors.
If your result points to a possible inherited trait, your clinician may recommend repeat testing after correcting iron deficiency, specialized hemoglobin studies, or genetic testing. In pregnancy or when planning a pregnancy, partner testing and counseling may be advised. Most findings are not an emergency; discuss your result with your clinician to decide on the next steps that fit your situation.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Iron deficiency can lower HbA2 and may mask an underlying carrier state. Repleting iron and retesting can clarify the true pattern.
Transfused red blood cells can change the measured hemoglobin fractions for several months, potentially obscuring your own HbA2 level.
Different analytical methods, such as HPLC or capillary electrophoresis, can yield slightly different results. Laboratories also apply method-specific quality controls.
Megaloblastic states from low B12 or folate can increase HbA2. Treating the deficiency may normalize the pattern.
Pregnancy can alter blood volume and red cell indices, which may influence interpretation. Your clinician will consider the clinical context.
Beta thalassemia trait often raises HbA2, while delta chain variants or some combined traits can lower it. Genetic testing may be needed for confirmation.
References